Emergent BioSolutions (EBS) Cost of Revenue (2011 - 2026)
Emergent BioSolutions (EBS) posted Cost of Revenue of $97.1 million for Q2 2026, up 34.86% on a QoQ basis from $72.0 million in Q1 2026, and up 45.14% year-over-year from $66.9 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Cost of Revenue (2011 - 2026) Analysis & Trends
Emergent BioSolutions has reported Cost of Revenue for 16 years, with the latest figure at $97.1 million in Q2 2026.
- On a quarterly basis, Cost of Revenue rose 45.14% year-over-year to $97.1 million in Q2 2026; TTM through Jun 2026 was $339.9 million, a 14.17% decrease from a year earlier, with the FY2025 full-year figure at $326.2 million, down 52.12% from the prior year.
- Cost of Revenue was $97.1 million for Q2 2026 at Emergent BioSolutions, up from $72.0 million in the prior quarter.
- The five-year high for Cost of Revenue was $296.1 million in Q2 2024, with the low at $66.9 million in Q2 2025.
- Average Cost of Revenue over 5 years is $140.2 million, with a median of $145.9 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Cost of Revenue surged 57.0% in 2022, then slumped 77.41% in 2025.
- Over 5 years, Cost of Revenue stood at $167.8 million in 2022, then climbed by 10.31% to $185.1 million in 2023, then slumped by 36.25% to $118.0 million in 2024, then retreated by 28.05% to $84.9 million in 2025, then increased by 14.37% to $97.1 million in 2026.
- The last three Cost of Revenue figures came in at $97.1 million (Q2 2026), $72.0 million (Q1 2026), and $84.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 8.05 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 4.29 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 4.40 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 3.71 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 4.09 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 3.73 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 3.51 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 174.53 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 97.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 97.10 Mn |
| Mar 31, 2026 | 72.00 Mn |
| Dec 31, 2025 | 84.90 Mn |
| Sep 30, 2025 | 85.90 Mn |
| Jun 30, 2025 | 66.90 Mn |
| Mar 31, 2025 | 88.50 Mn |
| Dec 31, 2024 | 118.00 Mn |
| Sep 30, 2024 | 122.60 Mn |
| Jun 30, 2024 | 296.10 Mn |
| Mar 31, 2024 | 144.60 Mn |
| Dec 31, 2023 | 185.10 Mn |
| Sep 30, 2023 | 176.80 Mn |
| Jun 30, 2023 | 190.60 Mn |
| Mar 31, 2023 | 152.90 Mn |
| Dec 31, 2022 | 167.80 Mn |
| Sep 30, 2022 | 147.20 Mn |
| Jun 30, 2022 | 169.80 Mn |
| Mar 31, 2022 | 155.90 Mn |
| Dec 31, 2021 | 145.00 Mn |
| Sep 30, 2021 | 114.30 Mn |
API Access
Emergent BioSolutions Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();